Skip to main content
Clinical Trials/NCT03445390
NCT03445390CompletedPhase 4

The Effect of Intravenous Acetaminophen on Post-Operative Pain After Craniotomy: A Randomized Control Trial

Stanford University1 site in 1 country27 target enrollmentStarted: May 1, 2014Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 4
Status
Completed
Enrollment
27
Locations
1
Primary Endpoint
Post-operative Opioid Consumption

Study Overview

Brief Summary

The purpose of the study is to determine the efficacy of IV acetaminophen when administered to neurosurgical patients at the beginning and end of their surgery. If the result is improved pain control with less opioid consumption postoperatively, then those patients may also experience less opioid related side effects such as nausea/vomiting, pruritus, and sedation. While numerous other studies have failed to show a benefit of IV acetaminophen after neurosurgical procedures, we are studying the administration of 1 g in two doses over the course of the operation.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Treatment
Masking
Double (Participant, Care Provider)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients with a diagnosis of bilateral moyamoya disease scheduled for bilateral external-carotid to internal-carotid bypass surgery to be done in two stages.

Exclusion Criteria

  • Allergy or history of reaction to acetaminophen. Patients with liver disease. Anyone not able to provide informed consent.

Arms & Interventions

Acetaminophen First

Experimental

Patients in this group are presenting for 2 surgeries and will be administered intravenous acetaminophen in one surgery and placebo in the other. Patients in this group will be randomized to receive acetaminophen first.

Intervention: Acetaminophen (Drug)

Acetaminophen First

Experimental

Patients in this group are presenting for 2 surgeries and will be administered intravenous acetaminophen in one surgery and placebo in the other. Patients in this group will be randomized to receive acetaminophen first.

Intervention: Placebo (Drug)

Placebo First

Experimental

Patients in this group are presenting for 2 surgeries and will be administered intravenous acetaminophen in one surgery and placebo in the other. Patients in this group will be randomized to receive placebo first.

Intervention: Acetaminophen (Drug)

Placebo First

Experimental

Patients in this group are presenting for 2 surgeries and will be administered intravenous acetaminophen in one surgery and placebo in the other. Patients in this group will be randomized to receive placebo first.

Intervention: Placebo (Drug)

Outcomes

Primary Outcomes

Post-operative Opioid Consumption

Time Frame: Up to 24 hours post-operative

From nursing records how much opioid was administered to each patient post-operatively. Opioid use was measured in micrograms (ug) of fentanyl.

Post-operative Pain

Time Frame: Up to 24 hours post-operative

Patients were asked to rate their pain on a scale of 1 to 10, with 1 being least pain, and 10 being most pain. Pain was assessed continually once per hour during the post-operative period and the average pain score calculated per participant. The average of the participants' average scores is presented for each group.

Secondary Outcomes

  • Count of Participants Requiring Anti-emetic Administration(Up to 24 hours post-operative)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Mark Burbridge

Principal Investigator

Stanford University

Study Sites (1)

Loading locations...

Similar Trials